Treatment options for sexual dysfunction in patients with chronic kidney disease: A systematic review of randomized controlled trials

Clinical Journal of the American Society of Nephrology

Volumn 5, Issue 6, 2010, Pages 985-995

  Vecchio, Mariacristina ^a   Navaneethan, Sankar D ^a,b   Johnson, David W ^d   Lucisano, Giuseppe ^a   Graziano, Giusi ^a   Querques, Marialuisa ^e   Saglimbene, Valeria ^a   Ruospo, Marinella ^a   Bonifati, Carmen ^a   Jannini, Emmanuele A ^f   Strippoli, Giovanni F M ^a,c,g,h  

^a Department of Clinical Pharmacology and Epidemiology Mario Negri Sud Consortium ^*  (Italy)

^b LERNER RESEARCH INSTITUTE   (United States)

^c University of Sydney   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e UNIVERSITY OF MILAN   (Italy)

^f UNIVERSITY OF L'AQUILA   (Italy)

^g NATIONAL HEALTH AND MEDICAL RESEARCH COUNCIL   (Australia)

^h Diaverum Medical Scientific Office   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; BROMOCRIPTINE; FOLLITROPIN; GONADOTROPIN; LUTEINIZING HORMONE; PHOSPHODIESTERASE V INHIBITOR; PLACEBO; SILDENAFIL; TESTOSTERONE; VARDENAFIL; ZINC; ZINC ACETATE; ZINC CHLORIDE; BIOLOGICAL MARKER; PHOSPHODIESTERASE INHIBITOR; PHOSPHODIESTERASE V;

BEHAVIOR THERAPY; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIALYSATE; DISEASE ASSOCIATION; FEMALE SEXUAL DYSFUNCTION; HORMONAL THERAPY; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; INTRACAVERNOUS DRUG ADMINISTRATION; MALE SEXUAL DYSFUNCTION; RANDOMIZED CONTROLLED TRIAL; REVIEW; SCORING SYSTEM; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; TREATMENT OUTCOME; ADULT; BLOOD; CHRONIC DISEASE; COMPLICATION; DIET SUPPLEMENTATION; ENZYMOLOGY; ERECTILE DYSFUNCTION; EVIDENCE BASED MEDICINE; FEMALE; KIDNEY DISEASE; MALE; METABOLISM; MIDDLE AGED; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEXUAL DYSFUNCTION, PHYSIOLOGICAL;

ADMINISTRATION, ORAL; ADULT; BIOLOGICAL MARKERS; CHRONIC DISEASE; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 5; DIETARY SUPPLEMENTS; ERECTILE DYSFUNCTION; EVIDENCE-BASED MEDICINE; FEMALE; FOLLICLE STIMULATING HORMONE, HUMAN; HUMANS; KIDNEY DISEASES; LUTEINIZING HORMONE; MALE; MIDDLE AGED; PHOSPHODIESTERASE 5 INHIBITORS; PHOSPHODIESTERASE INHIBITORS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; TESTOSTERONE; TREATMENT OUTCOME; ZINC;

EID: 77953300124     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.09081209     Document Type: Review

References (50)

1. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States. Prevalence and predictors. JAMA 281: 6, 1999
2. Finkelstein F, Shirani S, Wuerth D, Finkelstein SH: Therapy insight: Sexual dysfunction in patients with chronic kidney disease. Nat Clin Pract Nephrol 3: 200-207, 2007
3. Rosas S, Joffe M, Franklin E, Strom BL, Kotzker W, Brensinger C, Grossman E, Glasser D, Feldman H: Prevalence and determinants of erectile dysfunction in hemodialysis patients. Kidney Int 59: 2259-2266, 2001 (Pubitemid 32467619)
4. Anantharaman P, Schmidt RJ: Sexual function in chronic kidney disease. Adv Chronic Kid Dis 14: 119-125, 2007
5. Sharma RK, Prasad N, Gupta A, Kapoor R: Treatment of erectile dysfunction with sildenafil citrate in renal allograft recipients: A randomized double-blind, placebo-controlled, cross-over trial. Am J Kidney Dis 48: 128-133, 2006
6. Procci WR, Goldstein DA, Adelstein J, Massry SG: Sexual dysfunction in the male patients with uremia: A reappraisal. Kidney Int 19: 317-323, 1981 (Pubitemid 11145613)
7. Bellinghieri G, Santoro D, Mallamace A, Savica V: Sexual dysfunction in chronic renal failure. J Nephrol 21: s113-s117, 2008
8. Peng YS, Chiang CK, Kao TW, Hung KY, Lu CS, Chiang SS, Yang CS, Huang YC, Wu KD, Wu MS, Lien YR, Yang CC, Tsai DM, Chen PY, Liao CS, Tsai TJ, Chen WY: Sexual dysfunction in female haemodialysis patients: A multicenter study. Kidney Int 68: 760-765, 2005
9. Palmer BF: Sexual dysfunction in uremia. J Am Soc Nephrol 10: 1381-1388, 1999
10. Lawrence IG, Price DE, Howlett TA, Harris KP, Feehally J, Walls J: Erythropoietin and sexual dysfunction. Nephrol Dial Transplant 12: 741-747, 1997
11. Kutner NG: Quality of life and daily haemodialysis. Sem Dial 17: 92-98, 2004
12. Kimmel P, Peterson RA, Weihs KL, Immense SJ, Boyle WO, Kovac JA, Alleyne S, Cruz I, Veis JH. Psychologic functioning, quality of life, and behavioural compliance in patients beginning haemodialysis. J Am Soc Nephrol 7: 2152-2159, 1996
13. Campese VM. Autonomic nervous system dysfunction in uraemia. Nephrol Dial Transplant 5[Suppl 1]: s98-s101, 1990
14. Naya Y, Soh J, Ochiai A, Ushijima S, Kamoi K, Ukimura O, Kawauchi A, Fujito A, Ono T, Iwamoto N, Aoki T, Imada N, Marumo M, Miki T: Significant decrease of the international index of erectile function in male renal failure patients treated with haemodialysis. Int J Impot Res 14: 172-177, 2002
15. Mehrsai A, Mousavi S, Nikoobakht M, Khanlarpoor T, Shekarpour L, Pourmand G: Improvement of erectile dysfunction after kidney transplantation: The role of the associated factors. Urol J 3: 240-244, 2006
16. Al Khallaf HH. Analysis of sexual functions in male non-diabetic hemodialysis patients and renal transplant recipients. Transpl Int. 23: 176-181, 2009
17. Seidman SN, Roose SP: The sexual effects of testosterone replacement in depressed men: Randomized, placebo-controlled clinical trial. J Sex Marital Ther 32: 267-273, 2006
18. Turk S, Guney I, Altintepe L, Tonbul Z, Yildiz A, Yeksan M: Quality of life in male haemodialysis patients. Nephron Clin Pract 96: c21-c27, 2004
19. Goldestein I. The mutually reinforcing triad of depressive symptoms, cardiovascular disease, and erectile dysfunction. Am J Cardiol 86[Suppl]: 41F-45F, 2000
20. Padma-Nathan H, Stecher VJ, Sweeney M, Orazem J, Tseng LJ, Deriesthal H: Minimal time to successful intercourse after sildenafil citrate: Results of a randomized, double-blind, placebo-controlled trial. Urology 62: 400-403, 2003
21. Linet O, Ogrinc F. Efficacy and safety of intracavernosa alprostadil in men with erectile dysfunction. N Engl J Med 334: 873-877, 1996
22. Esposito K, Giugliano F, Di Palo C, Giugliano G, Marfella R, D'Andrea F, D'Armiento M, Giugliano D: Effect of lifestyle changes on erectile dysfunctions in obese men: A randomized controlled trial. JAMA 291: 2978-2984, 2004
23. Melnik T, Garcia Oliveira Soares B, Nasello AG. Psychosocial interventions for erectile dysfunction. In: Cochrane Database of Systematic Review 2007, Issue 3, CD004825
24. Vardi M, Nono A. Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus. In: Cochrane Database of Systematic Review 2007, Issue 1, CD002187
25. Higgins JP, Thompson SG: Quantifying heterogeneity in a meta-analysis. Stats Med 21: 1539-1558, 2002
26. Antoniou LD, Shalhoub RJ, Sudhakar T, Smith JC Jr: Reversal of uraemic impotence by zinc. Lancet 2: 895-898, 1977
27. Brook AC, Johnston DG, Ward MK, Watson MJ, Cook DB, Kerr DN: Absence of a therapeutic effect of zinc in the sexual dysfunction of haemodialysed patients. Lancet 2: 618-620, 1980
28. Demir E, Balal M, Paydas S, Sertdemir Y, Erken U: Efficacy and safety of vardenafil in renal transplant recipients with erectile dysfunction. Transplant Proc 38: 1379-1381, 2006
29. Yeksan M, Polat M, Türk S, Kazanci H, Akhan G, Erdogan Y, Erkul I: Effect of vitamin E therapy on sexual functions of uremic patients in hemodialysis. Int J Artif Organs 15: 648-652, 1992 (Pubitemid 23035822)
30. Mahajan SK, Abbasi AA, Prasad AS, Rabbani P, Briggs WA, McDonald FD: Effect of oral zinc therapy on gonadal function in hemodialysis patients. A double-blind study. Ann Intern Med 97: 357-361, 1982
31. Seibel I, Poli de Figueiredo CE, Telöken C, Moraes JF: Efficacy of oral sildenafil in hemodialysis patients with erectile dysfunction. J Am Soc Nephrol 13: 2770-2775, 2002
32. Wabrek AJ: Zinc: A possible role in the reversal of uremic impotence. Sexuality e Disability 5: 213-221, 1982
33. Yang J, Ju W, Zeng FQ, Xiao YJ, Zhang XP, Xiao CG: Efficacy and safety of vardenafil for kidney transplant recipients with erectile dysfunction. Zhonghua Nan Ke Xue 14: 911-913, 2008
34. Bellovich K, Provenzano R, Wankhede S. Effectiveness of sildenafil citrate in male hemodialysis patients. J Am Soc Nephrol 11: 139A, 2000
35. Blumberg A, Wildbolz A, Descoeudres C, Hennes U, Dambacher MA, Fischer JA, Weidmann P: Influence of 1,25 dihydroxycholecalciferol on sexual dysfunction and related endocrine parameters in patients on maintenance hemodialysis. Clin Nephrol 13: 208-214, 1980 (Pubitemid 10071972)
36. Bommer J, Ritz E, del Pozo E, Bommer G: Improved sexual function in male haemodialysis patients on bromocriptine. Lancet 2: 496-497, 1979 (Pubitemid 9256693)
37. Mahon A, Sidhu PS, Muir G, Macdougall IC: The efficacy of sildenafil for the treatment of erectile dysfunction in male peritoneal dialysis patients. Am J Kidney Dis 45: 381-387, 2005
38. Muir JW, Besser GM, Edwards CR, Rees LH, Cattell WR, Ackrill P, Baker LR: Bromocriptine improves reduced libido and potency in men receiving maintenance hemodialysis. Clin Nephrol 20: 308-314, 1983
39. Keating GM, Scott LJ: Vardenafil: A review of its use in erectile dysfunction. Drugs 63: 2673-2703, 2003
40. Markou S, Perimenis P, Gyftopoulos K, Athanasopoulos A, Barbalias G: Vardenafil (Levitra) for erectile dysfunction: A systematic review and meta-analysis of clinical trial reports. Int J Impot Res 16: 470-478, 2004
41. Tsertsvadze A, Fink HA, Yazdi F, Macdonald R, Bella AJ, Ansari MT, Garritty C, Soares-Weiser K, Daniel R, Sampson M, Fox S, Moher D, Wilt TJ. Oral phosphodiesterase-5 inhibitors and hormonal treatments for erectile dysfunction: A systematic review and meta-analysis. Ann Intern Med 151: 650-661, 2009
42. Miles CL, Candy B, Jones L, Williams R, Tookman A, King M. Interventions for sexual dysfunction following treatments for cancer. In: Cochrane Database of Systematic Review 2007, Issue 4, CD005540
43. Porst H, Rosen R, Padma-Nathan H, Goldstein I, Giuliano F, Ulbrich E, Bandel T: The efficacy and tolerability of vardenafil, a new phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: The first at home clinical trial. Int J Impot Res 13: 192-199, 2001
44. Carson CC, Rajfer J, Eardley I, Carrier S, Denne JS, Walker DJ, Shen W, Cordell WH: The efficacy and safety of tadalafil: An update. BJU Int 93: 1276-1281, 2004
45. Hellstrom WJ, Gittelman M, Karlin G, Segerson T, Thibonnier M, Taylor T, Padma-Nathan H: Vardenafil for treatment of men with erectile dysfunction: Efficacy and safety in a randomized, double-blind, placebo-controlled trial. J Androl 23: 763-771, 2002 (Pubitemid 36300965)
46. Aranda P, Ruilope LM, Calvo C, Luque M, Coca A, Gil de Miguel A: Erectile dysfunction in essential arterial hypertension and effects of sildenafil: Results of a Spanish national study. Am J Hypertens 17: 139-145, 2004
47. Qaseem A, Snow V, Denberg TD, Casey DE Jr, Forciea MA, Owens DK, Shekelle P; for the Clinical Efficacy Assessment Subcommittee of the American College of Physicians. Hormonal testing and pharmacologic treatment of erectile dysfunction: A clinical practice guideline from the American College of Physicians. Ann Intern Med 151: 639-649, 2009
48. D'Amati G, di Gioia CR, Bologna M, Giordano D, Giorgi M, Dolci S, Jannini EA. Type 5 phosphodiesterase expression in the human vagina. Urology 60: 191-195, 2002
49. Brown DA, Kyle JA, Ferrill MJ. Assessing the clinical efficacy of sildenafil for the treatment of female sexual dysfunction. Ann Pharmacother 43: 1275-1285, 2009
50. Peng YS, Chiang CK, Hung KY, Chiang SS,Lu CS, Yang CS, Wu KD, Yang CC, Lin RP, Chang CJ, Tsai TJ, Chen WY: The association of higher depressive symptoms and sexual dysfunction in male haemodialysis patients. Nephrol Dial Transplant 22: 857-861, 2007